Class information for:
Level 1: OVERACTIVE BLADDER//TOLTERODINE//ANTIMUSCARINIC

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
2472 2235 29.9 74%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
21 4 UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY 229838
214 3       URINARY INCONTINENCE//UROLOGY & NEPHROLOGY//NEUROUROLOGY AND URODYNAMICS 51394
36 2             URINARY INCONTINENCE//INTERNATIONAL UROGYNECOLOGY JOURNAL//NEUROUROLOGY AND URODYNAMICS 32345
2472 1                   OVERACTIVE BLADDER//TOLTERODINE//ANTIMUSCARINIC 2235

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OVERACTIVE BLADDER authKW 4284643 30% 46% 680
2 TOLTERODINE authKW 1634080 7% 75% 160
3 ANTIMUSCARINIC authKW 1482788 8% 65% 168
4 SOLIFENACIN authKW 1252182 5% 83% 110
5 OXYBUTYNIN authKW 1126794 6% 59% 141
6 FESOTERODINE authKW 889662 3% 96% 68
7 MIRABEGRON authKW 661136 3% 73% 66
8 PROPIVERINE authKW 647220 3% 82% 58
9 DARIFENACIN authKW 555153 2% 80% 51
10 TROSPIUM CHLORIDE authKW 371897 1% 83% 33

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Urology & Nephrology 65585 50% 0% 1112
2 Pharmacology & Pharmacy 2490 21% 0% 476
3 Obstetrics & Gynecology 1797 9% 0% 207
4 Medicine, General & Internal 896 11% 0% 240
5 Geriatrics & Gerontology 637 3% 0% 70
6 Health Policy & Services 242 2% 0% 44
7 Health Care Sciences & Services 175 2% 0% 52
8 Gerontology 63 1% 0% 19
9 Medicine, Research & Experimental 52 3% 0% 68
10 Primary Health Care 35 0% 0% 11

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 UROGYNAECOL 129807 3% 13% 71
2 BRISTOL UROL 104182 2% 14% 53
3 VANDERBILT CONTINENCE 83669 0% 88% 7
4 EVANSTON CONTINENCE 72494 1% 28% 19
5 UROL 71375 34% 1% 758
6 MED SCI CLIN 54638 0% 67% 6
7 UNIDAD UROL FUNC FEMENINA 36425 0% 67% 4
8 NEUROUROL PROGRAM 31041 0% 45% 5
9 CONTINENCE PELV HLTH 27321 0% 100% 2
10 DETROL 27321 0% 100% 2

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEUROUROLOGY AND URODYNAMICS 107834 6% 6% 137
2 LUTS-LOWER URINARY TRACT SYMPTOMS 48161 1% 12% 30
3 BJU INTERNATIONAL 31000 6% 2% 136
4 INTERNATIONAL UROGYNECOLOGY JOURNAL 25503 3% 2% 76
5 INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 16051 3% 2% 70
6 EUROPEAN UROLOGY 11446 3% 1% 78
7 ACTAS UROLOGICAS ESPANOLAS 10109 1% 3% 27
8 JOURNAL OF UROLOGY 10042 6% 1% 144
9 INTERNATIONAL NEUROUROLOGY JOURNAL 9620 1% 6% 12
10 UROLOGY 9311 5% 1% 106

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 OVERACTIVE BLADDER 4284643 30% 46% 680 Search OVERACTIVE+BLADDER Search OVERACTIVE+BLADDER
2 TOLTERODINE 1634080 7% 75% 160 Search TOLTERODINE Search TOLTERODINE
3 ANTIMUSCARINIC 1482788 8% 65% 168 Search ANTIMUSCARINIC Search ANTIMUSCARINIC
4 SOLIFENACIN 1252182 5% 83% 110 Search SOLIFENACIN Search SOLIFENACIN
5 OXYBUTYNIN 1126794 6% 59% 141 Search OXYBUTYNIN Search OXYBUTYNIN
6 FESOTERODINE 889662 3% 96% 68 Search FESOTERODINE Search FESOTERODINE
7 MIRABEGRON 661136 3% 73% 66 Search MIRABEGRON Search MIRABEGRON
8 PROPIVERINE 647220 3% 82% 58 Search PROPIVERINE Search PROPIVERINE
9 DARIFENACIN 555153 2% 80% 51 Search DARIFENACIN Search DARIFENACIN
10 TROSPIUM CHLORIDE 371897 1% 83% 33 Search TROSPIUM+CHLORIDE Search TROSPIUM+CHLORIDE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 SEXTON, CC , NOTTE, SM , MAROULIS, C , DMOCHOWSKI, RR , CARDOZO, L , SUBRAMANIAN, D , COYNE, KS , (2011) PERSISTENCE AND ADHERENCE IN THE TREATMENT OF OVERACTIVE BLADDER SYNDROME WITH ANTICHOLINERGIC THERAPY: A SYSTEMATIC REVIEW OF THE LITERATURE.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. VOL. 65. ISSUE 5. P. 567 -585 143 93% 56
2 SHAMLIYAN, T , WYMAN, JF , RAMAKRISHNAN, R , SAINFORT, F , KANE, RL , (2012) BENEFITS AND HARMS OF PHARMACOLOGIC TREATMENT FOR URINARY INCONTINENCE IN WOMEN A SYSTEMATIC REVIEW.ANNALS OF INTERNAL MEDICINE. VOL. 156. ISSUE 12. P. 861 -U153 147 80% 13
3 MAGGIORE, ULR , SALVATORE, S , ALESSANDRI, F , REMORGIDA, V , ORIGONI, M , CANDIANI, M , VENTURINI, PL , FERRERO, S , (2012) PHARMACOKINETICS AND TOXICITY OF ANTIMUSCARINIC DRUGS FOR OVERACTIVE BLADDER TREATMENT IN FEMALES.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 8. ISSUE 11. P. 1387 -1408 119 85% 8
4 BUSER, N , IVIC, S , KESSLER, TM , KESSELS, AGH , BACHMANN, LM , (2012) EFFICACY AND ADVERSE EVENTS OF ANTIMUSCARINICS FOR TREATING OVERACTIVE BLADDER: NETWORK META-ANALYSES.EUROPEAN UROLOGY. VOL. 62. ISSUE 6. P. 1040-1060 98 88% 46
5 MADHUVRATA, P , CODY, JD , ELLIS, G , HERBISON, GP , HAY-SMITH, EJC , (2012) WHICH ANTICHOLINERGIC DRUG FOR OVERACTIVE BLADDER SYMPTOMS IN ADULTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - 108 91% 11
6 REYNOLDS, WS , MCPHEETERS, M , BLUME, J , SURAWICZ, T , WORLEY, K , WANG, L , HARTMANN, K , (2015) COMPARATIVE EFFECTIVENESS OF ANTICHOLINERGIC THERAPY FOR OVERACTIVE BLADDER IN WOMEN A SYSTEMATIC REVIEW AND META-ANALYSIS.OBSTETRICS AND GYNECOLOGY. VOL. 125. ISSUE 6. P. 1423 -1432 83 92% 8
7 OEFELEIN, MG , (2011) SAFETY AND TOLERABILITY PROFILES OF ANTICHOLINERGIC AGENTS USED FOR THE TREATMENT OF OVERACTIVE BLADDER.DRUG SAFETY. VOL. 34. ISSUE 9. P. 733 -754 97 91% 24
8 CHAPPLE, C , OELKE, M , KAPLAN, SA , SCHOLFIELD, D , ARUMI, D , WAGG, AS , (2015) FESOTERODINE CLINICAL EFFICACY AND SAFETY FOR THE TREATMENT OF OVERACTIVE BLADDER IN RELATION TO PATIENT PROFILES: A SYSTEMATIC REVIEW.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 31. ISSUE 6. P. 1201 -1243 71 84% 5
9 KESSLER, TM , BACHMANN, LM , MINDER, C , LOHRER, D , UMBEHR, M , SCHUNEMANN, HJ , KESSELS, AGH , (2011) ADVERSE EVENT ASSESSMENT OF ANTIMUSCARINICS FOR TREATING OVERACTIVE BLADDER: A NETWORK META-ANALYTIC APPROACH.PLOS ONE. VOL. 6. ISSUE 2. P. - 73 84% 34
10 WAGG, A , NITTI, VW , KELLEHER, C , CASTRO-DIAZ, D , SIDDIQUI, E , BERNER, T , (2016) ORAL PHARMACOTHERAPY FOR OVERACTIVE BLADDER IN OLDER PATIENTS: MIRABEGRON AS A POTENTIAL ALTERNATIVE TO ANTIMUSCARINICS.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 32. ISSUE 4. P. 621 -638 76 64% 3

Classes with closest relation at Level 1


Rank Class id link
1 14559 NEUROGENIC DETRUSOR OVERACTIVITY//BOTULINUM TOXIN//ONABOTULINUMTOXINA
2 16506 NOCTURIA//NOCTURNAL POLYURIA//DESMOPRESSIN
3 420 URINARY INCONTINENCE//PELVIC FLOOR MUSCLE TRAINING//PELVIC FLOOR MUSCLES
4 32940 TERODILINE//BLADDER CONTRACTION INHIBITION//DETRUSOR CONTRACTION INHIBITION
5 499 DETRUSOR//BLADDER//URINARY BLADDER
6 26382 DULOXETINE//DULOXETINE HYDROCHLORIDE//GLOBAL PHARMACOKINET PHARMACODYNAM TRIAL SIMULAT
7 36824 CATHETER RELATED BLADDER DISCOMFORT//GE AFTSBEREICH MED MANAGEMENT MED CONTROLLING//DRG GRP
8 24631 SERUM ANTICHOLINERGIC ACTIVITY//ANTICHOLINERGIC BURDEN//ANTICHOLINERGIC ACTIVITY
9 5538 URODYNAMICS//PRESSURE FLOW STUDY//UROFLOWMETRY
10 29183 CURRENT PERCEPTION THRESHOLD//NEUROMETER//DENTURE SUPPORTING TISSUE

Go to start page